Wednesday 27 August 2014
 
»
Tag
 
»
Omrix Biopharmaceuticals

J&J to acquire Israel's Omrix for $465m

Johnson & Johnson Inc will acquire Israel's Omrix Biopharmaceuticals Inc for $27 a share, or a total of $465 million, the Globes financial news website said on Monday. Omrix, which makes biosurgical sealants for the prevention of b

Moreā€¦
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads